BioMarin Pharmaceutical Inc. (BMRN) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for BioMarin Pharmaceutical Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 32.67x | 29.26x | 108.03x | 135.44x | -252.11x | 18.56x |
| P/B Ratio | 1.87x | 2.21x | 3.66x | 4.17x | 3.79x | 3.86x |
| P/S Ratio | 3.54x | 4.38x | 7.49x | 9.15x | 8.75x | 8.52x |
| Profitability | ||||||
| Gross Margin | 77.1% | 79.7% | 78.0% | 76.0% | 74.5% | 71.8% |
| Operating Margin | 16.6% | 17.0% | 7.7% | 7.7% | -4.5% | -2.3% |
| Net Margin | 10.8% | 15.0% | 6.9% | 6.8% | -3.5% | 45.9% |
| EBITDA Margin | 17.8% | 22.8% | 12.7% | 12.7% | 2.6% | 4.5% |
| Liquidity | ||||||
| Current Ratio | 5.21x | 5.33x | 2.51x | 4.67x | 4.16x | 4.76x |
| Quick Ratio | 3.50x | 3.29x | 1.57x | 3.15x | 2.74x | 3.34x |
| Leverage | ||||||
| Debt/Equity | 0.11x | 0.11x | 0.22x | 0.24x | 0.26x | 0.26x |
YoY = year-over-year change. Source: FMP..